Everest Medicines Limited

1952.HK·HKSE·Healthcare
Compare
27.800+1.340 (+5.06%)today
At close: Nov 5, 4:08 PM HKT · May be delayed up to 15 min · HKD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close26.460
Open27.500
Day range27.44028.500
52-week range22.70050.300
Off day high−2.46%
Off 52-week high−44.73%
Volume6.06M
Avg. volume (3M)9.44M
Market cap9.83B
EPS (TTM)-0.1600
Forward P/E20.40
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding353.59M
Short interest—
Earnings dateAug 19, 2026
Analyst target40.899
Profit margin−2.24%

Against its peers

Compare in full ›
1952.HK SMZ1.F 688382.SS 6IB.F BMRN ZLAB
Market cap 9.83B 11.09B 8.38B 17.27B 11.07B 2.83B
P/E (TTM) — 31.2 — 123.8 — —
Forward P/E 20.4 — -43.8 — 9.0 -10.9
Price/book 1.3 2.6 6.6 6.2 1.8 4.2
Dividend yield — 2.90% — — — —
1-year change −44.53% −23.60% −48.70% −1.76% +10.20% −1.51%
Today +5.06% +1.45% +4.33% +3.42% +2.64% +3.83%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Everest Medicines's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Sino Biopharmaceutical LimitedSMZ1.F · Biotechnology 11.09B 0.6235 +1.45%
InventisBio Co., Limited688382.SS · Biotechnology 8.38B 14.45 +4.33%
Innovent Biologics, Inc.6IB.F · Biotechnology 17.27B 9.91 +3.42%
BioMarin Pharmaceutical Inc.BMRN · Biotechnology 11.07B 57.13 +2.64%
Zai Lab LimitedZLAB · Biotechnology 2.83B 22.80 +3.83%
Ligand Pharmaceuticals IncorporatedLGND · Biotechnology 6.32B 316.13 +0.83%
Shanghai Henlius Biotech, Inc.2696.HK · Biotechnology 27.67B 50.750 +1.78%
Insmed IncorporatedINSM · Biotechnology 24.13B 110.00 +5.32%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All 1952.HK news ›
@PRNewswire··3 outlets

Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. HONG KONG, Jun 26, 2026 - (ACN Newswire) - June 26, ...

LLYNVOAZN
More from 2 other outlets

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Positivesentiment

Mentioned with

U.S. Food and Drug Administration5Astrazeneca4Novo Nordisk4Pfizer4Ascentage Pharma3Hanmi Pharmaceutical3Novartis3Acumen Pharmaceuticals, Inc2

People in the coverage

Hengrui3Yifang WU3Abogen2Alan Bash2Daiichi Sankyo2Everest2

Themes

Pharmaceuticals5Biotechnology4China3Healthcare3Interim3Pharma3South Korea3The Asia Business Daily3

Most coverage from

  1. marketscreener.com10
  2. finance.biggo.com1
  3. markets.financialcontent.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance